Literature DB >> 5677337

Thiopental pharmacokinetics.

K B Bischoff, R L Dedrick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5677337     DOI： 10.1002/jps.2600570814

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  47 in total

1.  A whole-body physiologically based pharmacokinetic model incorporating dispersion concepts: short and long time characteristics.

Authors:  R E Oliver; A F Jones; M Rowland
Journal:  J Pharmacokinet Pharmacodyn       Date:  2001-02       Impact factor: 2.745

2.  Quantitative structure-pharmacokinetics relationships: II. A mechanistically based model to evaluate the relationship between tissue distribution parameters and compound lipophilicity.

Authors:  I Nestorov; L Aarons; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1998-10

3.  Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human.

Authors:  Dhaval K Shah; Alison M Betts
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-12-06       Impact factor: 2.745

4.  Significance of binding to Na,K-ATPase in the tissue distribution of ouabain in guinea pigs.

Authors:  H Harashima; M Mamiya; M Yamazaki; Y Sugiyama; Y Sawada; T Iga; M Hanano
Journal:  Pharm Res       Date:  1992-04       Impact factor: 4.200

5.  Simple model to explain effects of plasma protein binding and tissue binding on calculated volumes of distribution, apparent elimination rate constants and clearances.

Authors:  J G Wagner
Journal:  Eur J Clin Pharmacol       Date:  1976       Impact factor: 2.953

Review 6.  The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (Part II).

Authors:  W L Chiou
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

7.  A PBPK model describing a xenobiotic with a short PK event scale.

Authors:  Xiaofeng Wang; Brian E Davies
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-07-09       Impact factor: 2.745

Review 8.  Modeling kinetics of subcellular disposition of chemicals.

Authors:  Stefan Balaz
Journal:  Chem Rev       Date:  2009-05       Impact factor: 60.622

9.  Engineering targeted in vivo drug delivery. I. The physiological and physicochemical principles governing opportunities and limitations.

Authors:  C A Hunt; R D Macgregor; R A Siegel
Journal:  Pharm Res       Date:  1986-12       Impact factor: 4.200

10.  Single-cell and subcellular pharmacokinetic imaging allows insight into drug action in vivo.

Authors:  Greg M Thurber; Katy S Yang; Thomas Reiner; Rainer H Kohler; Peter Sorger; Tim Mitchison; Ralph Weissleder
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.